What Happened?
South San Francisco, CA-based PACT Pharma Appointed Timothy Moore as President and Chief Technology Officer
Date of management change: October 02, 2019
South San Francisco, CA-based PACT Pharma Appointed Timothy Moore as President and Chief Technology Officer
PACT Pharma is an independent, privately funded company recently launched by Arcus and scientific founders Jim Heath (Caltech), Toni Ribas (UCLA) and David Baltimore (Caltech). PACT`s vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer. Our mission is to leverage technology developed in the laboratories of Jim Heath and David Baltimore to advance the feasibility, affordability and clinical utilization of personalized neoantigen-specific adoptive cell therapy for cancer. PACT is developing personalized adoptive T cell therapies for the eradication of solid tumors. The identification of neo-epitopes that serve as private mutations for each patient`s cancer creates a unique opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens. PACT utilizes technology to identify T cells that recognize the neo-epitope. The unique T-cell receptor (TCR) sequences obtained from these neo-epitope-reactive cells are then engineered into T cells from the patient`s own blood to produce PACT`s therapeutic product: a tsunami of fresh, active T cells that, following infusion into the patient, recognize and attack each patient`s cancer cells.
Timothy Moore is Chief Technology Officer at Allogene. Previously, Timothy held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Goodale Grant, Murphy Sean, Barnes Nathan, Gordy Fred, Casullo Michael, Rosenman Herman, Rodriguiz Richy, Tippin Chad, Stanzione Jett, Ott Arthur, Gunnels Parrish
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.